Table 3.

Incidence of bleeding events according to the prescribed OACs and dosages

	MB, n/N (%)	CRNMB, n/N (%)
Dabigatran, appropriate dose	0/47 (0)	0/47 (0)
Dabigatran, inappropriate dose
Low dose	0/10 (0)	0/10 (0)
High dose	0/7 (0)	0/7 (0)
Rivaroxaban, Appropriate dose	3/61 (1.9)	1/61 (0.6)
Rivaroxaban, inappropriate dose
Low dose	1/13 (3.0)	0/13 (0)
High dose	0/7 (0)	0/7 (0)
Apixaban, Appropriate dose	1/77 (0.6)	0/77 (0)
Apixaban, inappropriate dose
Low dose	0/17 (0)	0/17 (0)
High dose	0/6 (0)	0/6 (0)
Edoxaban, Appropriate dose	0/25 (0)	0/25 (0)
Edoxaban, inappropriate dose
Low dose	1/2 (48.1)	0/2 (0)
High dose	0/1 (0)	0/1 (0)
Warfarin, appropriate dose	3/53 (1.7)	1/53 (0.6)
Warfarin, in appropriate dose	4/28 (4.2)	0/28 (0)

Data are expressed as the number (incidence rates). Incidence rates are events per 100 person‐years.

Abbreviations: MB, major bleeding; CRNMB, clinically relevant non‐major bleeding.